Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).

Anaïs EssiliniThibault ComontJohanne GermainNatacha BrunClaire DingremontBrice CastelSophie AristaSerge MadauleLaurent SaillerMaryse Lapeyre-MestreOdile Beyne-RauzyBertrand GodeauDaniel AdoueGuillaume Moulisnull null

Published in: European journal of haematology (2018)

Initiating methylprednisolone at a conventional dose provided no significant benefit compared to giving oral prednisone only to adults with ITP.

Keyphrases

high dose
newly diagnosed
low dose
adipose tissue
weight loss
glycemic control